The most frequent genetic aberration associated with malignant glioma is an amplification of the EGFR, also referred to as ERBB1 or human epidermal receptor 1 (HER1), and the expression of the EGFR variant III (EGFRvIII). The gene discussed is EGFR; the disease is malignant glioma.